A quiet revolution in tuberculosis diagnostics is here. 🧪🌍
This NEJM study shows that MiniDock MTB, a rapid swab-based molecular test, delivers Xpert-level accuracy with minimal training and no adverse events—all in a near–point-of-care format. ⏱️🧠
Key insights:
🔹 Sensitivity: 85.7% (sputum), 79.6% (tongue)
🔹 Specificity: >97–99%
🔹 Strong performance vs smear microscopy (+24% sensitivity)
🔹 Usability score: 75—ready for real-world deployment
The implications are profound:
👉 Noninvasive testing for patients unable to produce sputum
👉 Decentralized diagnostics in resource-limited settings
👉 A realistic path to closing the global TB detection gap
From central labs to community clinics—this is how access scales. 🚀
📖 Yerlikaya et al., NEJM 2026
#Tuberculosis #GlobalHealth #Diagnostics #PointOfCare #PublicHealth #InfectiousDiseases #PrecisionMedicine #MedicalInnovation #HealthEquity #TBElimination
